Relmada Therapeutics, Inc. (RLMD)
7.235
+0.20
(+2.92%)
USD |
NASDAQ |
Apr 28, 16:00
7.235
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Market Cap : 758.88M for April 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.594B |
| Theravance Biopharma, Inc. | 863.54M |
| Avalo Therapeutics, Inc. | 292.38M |
| AN2 Therapeutics, Inc. | 170.00M |
| ACADIA Pharmaceuticals, Inc. | 3.866B |
Market Cap Related Metrics
| Price to Book Value | 8.772 |
| Price | 7.235 |
| Earnings Yield | -20.32% |